|Venture Round, 8/2007 |
Stanford Financial Group
|Partial Close, 1/2010 ||$5.55M|
|Partial Close, 11/2011 ||$3.75M|
|Private Equity, 8/2013 ||$2M|
|Debt, 12/2012 ||$1.04M|
KineMed Inc., based in Emeryville, California, was founded in 2001. A decade later, we are a field-leading US biotech company that serves major pharmaceutical clients by making predictions of efficacy and toxicity to accelerate and reduce the cost of drug development.
KineMed’s unique, patented isotopic tracer technology enables our clients to track key chemical pathways within living systems.
Combined with deep expertise, we offer unparalleled insight into the complex biological processes underlying the root causes of disease.